Oxbow Advisors LLC Has $1.72 Million Stake in The Procter & Gamble Company (NYSE:PG)

Oxbow Advisors LLC grew its holdings in The Procter & Gamble Company (NYSE:PG) by 3.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,917 shares of the company’s stock after purchasing an additional 303 shares during the quarter. Oxbow Advisors LLC’s holdings in Procter & Gamble were worth $1,718,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the company. Acorn Creek Capital LLC lifted its stake in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after buying an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. grew its holdings in Procter & Gamble by 1.1% in the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Alera Investment Advisors LLC boosted its stake in shares of Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after acquiring an additional 60 shares during the last quarter. Hudson Value Partners LLC boosted its stake in shares of Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after acquiring an additional 60 shares during the last quarter. Finally, Traveka Wealth LLC lifted its position in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after buying an additional 60 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Up 2.6 %

Procter & Gamble stock opened at $167.71 on Friday. The stock has a 50-day simple moving average of $171.08 and a 200 day simple moving average of $168.15. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market capitalization of $394.96 billion, a P/E ratio of 28.92, a PEG ratio of 3.48 and a beta of 0.42. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the business posted $1.83 earnings per share. The business’s revenue for the quarter was down .6% compared to the same quarter last year. Analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.31%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of research reports. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a report on Monday, September 30th. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Thursday, August 29th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley lifted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Insider Transactions at Procter & Gamble

In other news, CEO Jon R. Moeller sold 31,797 shares of the company’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the transaction, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $50,897,483.94. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Jon R. Moeller sold 31,797 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $5,380,688.34. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at $50,897,483.94. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 313,597 shares of company stock worth $53,268,499. Corporate insiders own 0.18% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.